Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-4,721
Closed -$320K 424
2015
Q2
$320K Sell
4,721
-2,605
-36% -$184K ﹤0.01% 304
2015
Q1
$435K Sell
7,326
-37,160
-84% -$2.12M 0.01% 334
2014
Q4
$2.51M Sell
44,486
-1,563
-3% -$83.9K 0.02% 157
2014
Q3
$2.1M Buy
46,049
+31,163
+209% +$1.51M 0.02% 185
2014
Q2
$767K Buy
14,886
+8,945
+151% +$440K 0.03% 299
2014
Q1
$290K Sell
5,941
-28,963
-83% -$1.41M 0.01% 446
2013
Q4
$1.51M Buy
34,904
+4,566
+15% +$188K 0.04% 320
2013
Q3
$1.16M Sell
30,338
-88,307
-74% -$3.11M 0.03% 382
2013
Q2
$3.68M Buy
+118,645
New +$3.54M 0.05% 229

Other funds holding VTRS

NatWest Group's VTRS Position: Q3 2015 in Review

NatWest Group sold out of Viatris (VTRS) in Q3 2015, closing a stake of 4,721 shares — an estimated $320K sold.

NatWest Group first reported a position in VTRS in Q2 2013 and held it in 9 quarters. The position peaked at $3.68M in Q2 2013. 612 funds tracked by Wall St. Rank hold VTRS as of Q3 2015.

  • NatWest Group reported no remaining Viatris position as of Q3 2015 after selling out during the quarter.
  • NatWest Group sold 4,721 Viatris shares in Q3 2015, an estimated $320K.
  • NatWest Group first reported a position in Viatris in Q2 2013 and held it in 9 quarters.
  • NatWest Group's Viatris position peaked at $3.68M in Q2 2013.
  • 612 funds tracked by Wall St. Rank held Viatris as of Q3 2015.

Based on NatWest Group's 13F filing for Q3 2015, filed 13 Nov 2015.